Search

everythinglearnresearchcommunity

for

Search:↓

A Chinese male with a new genetic mutation has a skin condition and severe urinary issues, with treatments having mixed success.

MSUD patients need careful monitoring of amino acids and zinc to prevent severe symptoms.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Dermoscopy now helps diagnose various skin, hair, and nail issues, improving patient care and treatment understanding.

A child's hair loss after Kawasaki disease may help understand the disease's autoimmune causes.

Monilethrix causes fragile, patchy hair loss.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

More research is needed to understand how hair keratins work and their role in hair disorders.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Hair mineral analysis might help diagnose diseases early, but standard methods are needed.

About 43% of people in Europe have had a skin condition in the past year, with fungal infections, acne, and eczema being the most common.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

A young woman's Cronkhite-Canada syndrome improved on its own after she gave birth.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.